KRYS insider transaction filings
Krystal Biotech, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-16. Screen KRYS transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 10 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 35 legs across 4 filings by 4 insiders — 76,000 shares, $26,541,292 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 7,428 shares @ $329.60 ($2,448,280) by ROSSI DINO A, filed 2026-08-14.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Krishnan Krish S — President and CEO, Director, 10% owner | 1 | — | 13 legs · 25,000 sh · $8,983,084 | — |
| Krishnan Suma — President, R&D, Director, 10% owner | 1 | — | 13 legs · 25,000 sh · $8,982,986 | — |
| ROSSI DINO A — Director | 2 | — | 8 legs · 25,000 sh · $8,227,953 | 3 |
| Thomas John Charles — EVP, General Counsel | 1 | — | 1 leg · 1,000 sh · $347,270 | 2 |
| Gangolli Julian S — Director | 1 | — | — | 2 |
| JANNEY DANIEL — Director | 1 | — | — | 2 |
| Mason Christopher — Director | 1 | — | — | 2 |
| Mazzacco Catherine — Director | 1 | — | — | 2 |
| Sutherland Everett Rand — Director | 1 | — | — | 2 |
Recent Form 4 filings — Krystal Biotech, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | Sutherland Everett Rand — Director | Grant/award (A): 1,187 (derivative) @ $0 · Grant/award (A): 471 (derivative) @ $0 | EDGAR |
| 2026-09-16 | 4 | ROSSI DINO A — Director | Grant/award (A): 1,187 (derivative) @ $0 · Grant/award (A): 471 (derivative) @ $0 | EDGAR |
| 2026-09-16 | 4 | Gangolli Julian S — Director | Grant/award (A): 1,187 (derivative) @ $0 · Grant/award (A): 471 (derivative) @ $0 | EDGAR |
| 2026-09-16 | 4 | JANNEY DANIEL — Director | Grant/award (A): 1,187 (derivative) @ $0 · Grant/award (A): 471 (derivative) @ $0 | EDGAR |
| 2026-09-16 | 4 | Mason Christopher — Director | Grant/award (A): 1,187 (derivative) @ $0 · Grant/award (A): 471 (derivative) @ $0 | EDGAR |
| 2026-09-16 | 4 | Mazzacco Catherine — Director | Grant/award (A): 1,187 (derivative) @ $0 · Grant/award (A): 471 (derivative) @ $0 | EDGAR |
| 2026-09-04 | 4 | Krishnan Krish S — President and CEO, Director, 10% owner | Sale (S): 520 @ $354.54 · Sale (S): 2,029 @ $355.57 · Sale (S): 3,297 @ $356.37 · Sale (S): 3,981 @ $357.57 · Sale (S): 3,143 @ $358.42 · Sale (S): 3,357 @ $359.39 · +7 more | EDGAR |
| 2026-09-04 | 4 | Krishnan Suma — President, R&D, Director, 10% owner | Sale (S): 520 @ $354.54 · Sale (S): 2,006 @ $355.57 · Sale (S): 3,267 @ $356.37 · Sale (S): 3,962 @ $357.57 · Sale (S): 3,180 @ $358.42 · Sale (S): 3,392 @ $359.39 · +7 more | EDGAR |
| 2026-08-14 | 4 | ROSSI DINO A — Director | Gift (G): 3,691 @ $0 · Sale (S): 341 @ $325.60 · Sale (S): 2,287 @ $326.60 · Sale (S): 5,226 @ $327.39 · Sale (S): 1,687 @ $328.52 · Sale (S): 7,428 @ $329.60 · +3 more | EDGAR |
| 2026-06-26 | 4 | Thomas John Charles — EVP, General Counsel | Option exercise (M): 1,000 @ $179.25 · Sale (S): 1,000 @ $347.27 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Krishnan Suma — President, R&D, Director, 10% owner | Sale (S): 320 @ $300.75 · Sale (S): 593 @ $302.25 · Sale (S): 247 @ $303.17 · Sale (S): 400 @ $304.89 · Sale (S): 480 @ $305.87 · Sale (S): 1,348 @ $307.09 · +5 more | EDGAR |
| 2026-06-05 | 4 | Krishnan Krish S — President and CEO, Director, 10% owner | Sale (S): 320 @ $300.75 · Sale (S): 640 @ $302.24 · Sale (S): 176 @ $303.17 · Sale (S): 544 @ $304.81 · Sale (S): 589 @ $306.33 · Sale (S): 11,461 @ $307.68 · +5 more | EDGAR |
| 2026-05-27 | 4 | Thomas John Charles — EVP, General Counsel | Sale (S): 642 @ $302.03 | EDGAR |
| 2026-03-06 | 4 | Krishnan Suma — President, R&D, Director, 10% owner | Sale (S): 407 @ $257.32 · Sale (S): 589 @ $258.54 · Sale (S): 668 @ $259.61 · Sale (S): 3,667 @ $260.37 · Sale (S): 2,931 @ $261.41 · Sale (S): 1,938 @ $262.35 · +4 more | EDGAR |
| 2026-03-06 | 4 | Krishnan Krish S — President and CEO, Director, 10% owner | Sale (S): 483 @ $257.31 · Sale (S): 470 @ $258.38 · Sale (S): 1,377 @ $259.87 · Sale (S): 3,128 @ $260.49 · Sale (S): 2,962 @ $261.41 · Sale (S): 2,380 @ $262.44 · +4 more | EDGAR |
| 2026-03-03 | 4 | ROMANO KATHRYN — Chief Accounting Officer | Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,262 @ $275.64 · Option exercise (M): 550 @ $0 · Tax withholding (F): 240 @ $275.64 · Sale (S): 750 @ $267.60 · Option exercise (M): 7,500 (derivative) @ $0 · +3 more | EDGAR |
| 2026-03-03 | 4 | Krishnan Suma — President, R&D, Director, 10% owner | Option exercise (M): 22,500 @ $0 · Tax withholding (F): 10,236 @ $275.64 · Option exercise (M): 4,000 @ $0 · Tax withholding (F): 1,820 @ $275.64 · Option exercise (M): 8,750 @ $0 · Tax withholding (F): 3,981 @ $275.64 · +9 more | EDGAR |
| 2026-03-03 | 4 | Krishnan Krish S — President and CEO, Director, 10% owner | Option exercise (M): 8,750 @ $0 · Tax withholding (F): 3,981 @ $275.64 · Option exercise (M): 26,250 @ $0 · Tax withholding (F): 11,942 @ $275.64 · Option exercise (M): 5,725 @ $0 · Tax withholding (F): 2,605 @ $275.64 · +9 more | EDGAR |
| 2026-03-03 | 4 | JANNEY DANIEL — Director | Sale (S): 9,430 @ $275.45 · Sale (S): 2,373 @ $276.17 | EDGAR |
| 2026-02-26 | 4 | JANNEY DANIEL — Director | Option exercise (M): 37,895 @ $2.46 · Sale (S): 569 @ $262.91 · Sale (S): 1,733 @ $264.12 · Sale (S): 3,557 @ $265.08 · Sale (S): 8,986 @ $266.18 · Sale (S): 11,673 @ $266.97 · +16 more | EDGAR |
| 2026-02-23 | 4 | ROSSI DINO A — Director | Option exercise (M): 18,950 @ $8.79 · Sale (S): 8,116 @ $260.49 · Sale (S): 10,834 @ $262.10 · Option exercise (M): 18,950 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | ROMANO KATHRYN — Chief Accounting Officer | Option exercise (M): 12,500 @ $63.55 · Sale (S): 2,000 @ $270.56 · Sale (S): 5,700 @ $271.66 · Sale (S): 2,824 @ $272.51 · Sale (S): 928 @ $273.71 · Sale (S): 552 @ $274.64 · +4 more | EDGAR |
| 2025-12-05 | 4 | Krishnan Suma — President, R&D, Director, 10% owner | Sale (S): 700 @ $214.25 · Sale (S): 600 @ $215.49 · Sale (S): 1,400 @ $216.97 · Sale (S): 3,593 @ $218.83 · Sale (S): 5,419 @ $219.68 · Sale (S): 2,627 @ $220.52 · +11 more | EDGAR |
| 2025-12-05 | 4 | Krishnan Krish S — President and CEO, Director, 10% owner | Sale (S): 956 @ $214.28 · Sale (S): 344 @ $215.48 · Sale (S): 1,600 @ $217.04 · Sale (S): 2,577 @ $218.72 · Sale (S): 5,693 @ $219.55 · Sale (S): 2,625 @ $220.34 · +11 more | EDGAR |
| 2025-07-16 | 4 | Krishnan Suma — President, R&D, Director, 10% owner | Sale (S): 13,335 @ $150.29 · Sale (S): 100 @ $151 · Sale (S): 2,236 @ $150.68 · Sale (S): 800 @ $151.79 · Sale (S): 1,529 @ $150 · Sale (S): 13,400 @ $150.30 · +3 more | EDGAR |
| 2025-07-16 | 4 | Krishnan Krish S — President and CEO, Director, 10% owner | Sale (S): 13,400 @ $150.30 · Sale (S): 2,184 @ $150.68 · Sale (S): 900 @ $151.79 · Sale (S): 1,389 @ $150 · Sale (S): 13,335 @ $150.29 · Sale (S): 100 @ $151 · +3 more | EDGAR |
| 2025-07-11 | 4 | Krishnan Suma — President, R&D, Director, 10% owner | Sale (S): 200 @ $150.14 · Sale (S): 6,500 @ $150.23 · Sale (S): 300 @ $151.39 · Sale (S): 200 @ $150.07 · Sale (S): 6,627 @ $150.22 · Sale (S): 300 @ $151.39 | EDGAR |
| 2025-07-11 | 4 | Krishnan Krish S — President and CEO, Director, 10% owner | Sale (S): 200 @ $150.07 · Sale (S): 6,627 @ $150.22 · Sale (S): 300 @ $151.39 · Sale (S): 200 @ $150.14 · Sale (S): 6,500 @ $150.23 · Sale (S): 300 @ $151.39 | EDGAR |
| 2025-06-30 | 4 | Mazzacco Catherine — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Sutherland Everett Rand — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Mason Christopher — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Gangolli Julian S — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | ROSSI DINO A — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | JANNEY DANIEL — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Krishnan Suma — President, R&D, Director, 10% owner | Sale (S): 1,639 @ $175.97 · Sale (S): 4,579 @ $176.88 · Sale (S): 10,937 @ $177.66 · Sale (S): 6,514 @ $178.76 · Sale (S): 1,331 @ $179.55 · Sale (S): 1,100 @ $175.83 · +4 more | EDGAR |
| 2025-03-13 | 4 | Krishnan Krish S — President and CEO, Director, 10% owner | Sale (S): 1,100 @ $175.83 · Sale (S): 4,944 @ $176.80 · Sale (S): 10,931 @ $177.62 · Sale (S): 6,769 @ $178.77 · Sale (S): 1,256 @ $179.57 · Sale (S): 1,639 @ $175.97 · +4 more | EDGAR |
| 2025-02-28 | 4 | ROMANO KATHRYN — Chief Accounting Officer | Tax withholding (F): 2,268 @ $176.39 · Sale (S): 750 @ $175.22 · Option exercise (M): 5,000 @ $0 · Tax withholding (F): 2,315 @ $179.25 · Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,471 @ $179.25 · +4 more | EDGAR |
| 2025-02-28 | 4 | Krishnan Krish S — President and CEO, Director, 10% owner | Tax withholding (F): 4,721 @ $176.39 · Option exercise (M): 12,500 @ $0 · Tax withholding (F): 5,786 @ $179.25 · Option exercise (M): 8,750 @ $0 · Tax withholding (F): 4,050 @ $179.25 · Option exercise (M): 26,250 @ $0 · +11 more | EDGAR |
| 2025-02-28 | 4 | Krishnan Suma — President, R&D, Director, 10% owner | Tax withholding (F): 3,286 @ $176.39 · Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,471 @ $179.25 · Option exercise (M): 22,500 @ $0 · Tax withholding (F): 10,414 @ $179.25 · Option exercise (M): 12,500 @ $0 · +10 more | EDGAR |
| 2024-12-13 | 4 | Krishnan Suma — President, R&D, Director, 10% owner | Sale (S): 5,942 @ $163.04 · Sale (S): 8,923 @ $163.92 · Sale (S): 4,723 @ $164.91 · Sale (S): 2,114 @ $165.79 · Sale (S): 798 @ $166.96 · Sale (S): 200 @ $168.31 · +11 more | EDGAR |
| 2024-12-13 | 4 | Krishnan Krish S — President and CEO, Director, 10% owner | Sale (S): 6,302 @ $163.07 · Sale (S): 8,381 @ $163.91 · Sale (S): 4,909 @ $164.93 · Sale (S): 1,977 @ $165.82 · Sale (S): 923 @ $166.93 · Sale (S): 911 @ $169.65 · +11 more | EDGAR |
| 2024-09-13 | 4 | Krishnan Suma — President, R&D, Director, 10% owner | Sale (S): 8,497 @ $195.43 · Sale (S): 2,727 @ $196.07 · Sale (S): 1,385 @ $197.55 · Sale (S): 3,392 @ $198.43 · Sale (S): 2,945 @ $199.22 · Sale (S): 4,159 @ $200.41 · +9 more | EDGAR |
| 2024-09-13 | 4 | Krishnan Krish S — President and CEO, Director, 10% owner | Sale (S): 3,957 @ $195.16 · Sale (S): 6,458 @ $195.72 · Sale (S): 1,696 @ $197.04 · Sale (S): 2,086 @ $198.08 · Sale (S): 4,008 @ $198.93 · Sale (S): 3,600 @ $200.15 · +9 more | EDGAR |
| 2024-09-13 | 4 | ROSSI DINO A — Director | Gift (G): 5,000 @ $0 | EDGAR |
| 2024-07-01 | 4 | Mazzacco Catherine — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Sutherland Everett Rand — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Mason Christopher — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Gangolli Julian S — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | ROSSI DINO A — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | JANNEY DANIEL — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Krystal Biotech, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-04 | 8-K | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-03 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2025-10-22 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KRYS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →